Consistent with this finding, NBR2 led to decreased cell cycle progression, but increased autophagy, which down-regulated apoptosis under energy stress and inhibited the progression of breast and kidney cancers, suggesting that NBR2 is a tumor suppressor that regulates AMPK activity. Here, PRKAA1 is linked to kidney cancer.